Infectious Diseases
The evidence indicates that two simian immunodeficiency viruses (SIV), one from Chimpanzees (SIVcpz) and the other from sooty mangabeys (SIVsm), crossed the species barrier to humans, generating HIV-1 and HIV-2, respectively. The importance of characterizing the prevalence, geographic distribution, and genetic diversity of naturally occurring SIV infections to investigate whether humans continue to be exposed to SIV and if such exposure could lead to additional zoonotic transmissions. Through vigorous efforts made in the past two centuries, public health workers have succeeded in developing vaccines, antibiotics, and chemotherapeutics, and as a result most infectious diseases have been brought under control in industrialized countries. However, in developing countries, infectious diseases have been harder to contain, and the increase in migration and movement of populations in the last two decades has made national boundaries disappear as far as the transmission of infection is concerned. Some diseases, such as malaria, have been eradicated from industrialized countries mainly through extensive work on vector control, but their presence in developing countries has increased because of neglect or drug resistance. One of these proteases (Histidine Aspartic Protease, HAP) is homologous to three other aspartic proteases involved in hemoglobin metabolism but has a histidine in place of one of the two aspartic acids involved in catalysis.
- The Growing Challenge of Antibiotic Resistance
- Antibodies for Pediatrics Diseases
- Therapeutic Antibodies for Neurological Disease and other Neglected Diseases
- Novel Therapeutic Antibodies for Infectious and Inflammatory Diseases
- Novel Therapeutic Antibodies for Allergy, Asthma and Autoimmune Diseases
Related Conference of Infectious Diseases
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
International Conference on Tumor Immunology and Immunotherapy
International Conference on Mucosal Immunology
International Conference on Cancer Immunology and Immunotherapy
2nd International Conference on Parasitology
International Conference on Autoimmunity
2nd International Congress on Neuroimmunology and Therapeutics
5th International Conference on Immunology
2nd International Conference on Innate Immunity
International Allergy Conference
2nd World Congress on Infectious Diseases
Americas Antibody Congress
World Bispecific Antibody Summit
Antibodies in Drug Discovery
11th Annual Biomarkers Congress
6th World ADC Summit
Bio Process International European Summit
Protein Antibody Engineering and Development Summit
Antibody Biology Engineering
Proteins and Antibodies Congress
8th Annual International Congress of Antibodies
Cell Culture Engineering XV
Antibody Engineering and Therapeutics
Protein and Antibody Engineering Summit
Infectious Diseases Conference Speakers
Recommended Sessions
- Anti-Cancer Antibodies
- Antibodies Immunogenecity
- Antibodies in Pregnancy
- Antibodies Structure
- Antibody Drug Conjugate
- Antibody Drug Therapy
- Antibody Engineering
- Antibody Humanization Technologies
- Antibody Tests
- Antigens
- Auto Antibodies
- Autoimmune Antibodies
- Biomarkers Development
- Biosimilar monoclonal antibodies
- Cancer Immune therapy
- Hepatitis Antibodies
- Immunoglobulins Structures
- Immunotherapy and Immune Checkpoints
- Infectious Diseases
- Insulin and Diode Antibodies
- Medical Applications
- Monoclonal Antibody Therapy
- Myeloperoxidase Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)